| Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis CJL Murray, KS Ikuta, F Sharara, L Swetschinski, GR Aguilar, A Gray, ... The lancet 399 (10325), 629-655, 2022 | 7681 | 2022 |
| A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis S Verstovsek, RA Mesa, J Gotlib, RS Levy, V Gupta, JF DiPersio, ... New England Journal of Medicine 366 (9), 799-807, 2012 | 2238 | 2012 |
| Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia LI Shlush, S Zandi, A Mitchell, WC Chen, JM Brandwein, V Gupta, ... Nature 506 (7488), 328-333, 2014 | 1612 | 2014 |
| Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 JB Soriano, PJ Kendrick, KR Paulson, V Gupta, EM Abrams, RA Adedoyin, ... The Lancet Respiratory Medicine 8 (6), 585-596, 2020 | 1473 | 2020 |
| Epidemiology and outcomes of health-care–associated pneumonia: results from a large US database of culture-positive pneumonia MH Kollef, A Shorr, YP Tabak, V Gupta, LZ Liu, RS Johannes Chest 128 (6), 3854-3862, 2005 | 1306 | 2005 |
| Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of … H Wang, ZA Bhutta, MM Coates, M Coggeshall, L Dandona, K Diallo, ... The Lancet 388 (10053), 1725-1774, 2016 | 852 | 2016 |
| Risk factors for acute GVHD and survival after hematopoietic cell transplantation M Jagasia, M Arora, MED Flowers, NJ Chao, PL McCarthy, CS Cutler, ... Blood, The Journal of the American Society of Hematology 119 (1), 296-307, 2012 | 792 | 2012 |
| A 17-gene stemness score for rapid determination of risk in acute leukaemia SWK Ng, A Mitchell, JA Kennedy, WC Chen, J McLeod, N Ibrahimova, ... Nature 540 (7633), 433-437, 2016 | 781 | 2016 |
| International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium AC Harris, R Young, S Devine, WJ Hogan, F Ayuk, U Bunworasate, ... Biology of Blood and Marrow Transplantation 22 (1), 4-10, 2016 | 663 | 2016 |
| Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with … BL McClune, DJ Weisdorf, TL Pedersen, G Tunes da Silva, MS Tallman, ... Journal of Clinical Oncology 28 (11), 1878-1887, 2010 | 548 | 2010 |
| Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India DK Kochar, A Das, SK Kochar, V Saxena, P Sirohi, S Garg, A Kochar, ... American Journal of Tropical Medicine and Hygiene 80 (2), 194, 2009 | 518 | 2009 |
| Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure M Duval, JP Klein, W He, JY Cahn, M Cairo, BM Camitta, R Kamble, ... Journal of clinical oncology 28 (23), 3730-3738, 2010 | 517 | 2010 |
| Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic … MB Reitsma, PJ Kendrick, E Ababneh, C Abbafati, M Abbasi-Kangevari, ... The Lancet 397 (10292), 2337-2360, 2021 | 501 | 2021 |
| Trends in disease severity and health care utilization during the early Omicron variant period compared with previous SARS-CoV-2 high transmission periods—United States … AD Iuliano MMWR. Morbidity and mortality weekly report 71, 2022 | 421 | 2022 |
| Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends … DM Merino, LM McShane, D Fabrizio, V Funari, SJ Chen, JR White, ... Journal for immunotherapy of cancer 8 (1), 2020 | 395 | 2020 |
| Healthcare-associated bloodstream infection: a distinct entity? Insights from a large US database AF Shorr, YP Tabak, AD Killian, V Gupta, LZ Liu, MH Kollef Critical care medicine 34 (10), 2588-2595, 2006 | 391 | 2006 |
| Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial S Verstovsek, RA Mesa, J Gotlib, V Gupta, JF DiPersio, JV Catalano, ... Journal of hematology & oncology 10, 1-14, 2017 | 386 | 2017 |
| Outcome following admission to UK intensive care units after cardiac arrest: a secondary analysis of the ICNARC Case Mix Programme Database JP Nolan, SR Laver, CA Welch, DA Harrison, V Gupta, K Rowan Anaesthesia 62 (12), 1207-1216, 2007 | 370 | 2007 |
| Outcome of transplantation for myelofibrosis KK Ballen, S Shrestha, KA Sobocinski, MJ Zhang, A Bashey, BJ Bolwell, ... Biology of Blood and Marrow Transplantation 16 (3), 358-367, 2010 | 341 | 2010 |
| Pacritinib vs best available therapy, including ruxolitinib, in patients with myelofibrosis: a randomized clinical trial J Mascarenhas, R Hoffman, M Talpaz, AT Gerds, B Stein, V Gupta, ... JAMA oncology 4 (5), 652-659, 2018 | 337 | 2018 |
